Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Apr 13, 2026
- Accession no.
- 0001106578-26-000031
- Filed
- Apr 13, 2026
- Trade date
- Apr 10, 2026
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 8 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.41M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (Chairperson & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 10, 2026 | Common Stock | MOption exerciseAcquired | +9,500 | $146.03 | +$1,387,285 | 50,013 | Direct | |
| Apr 10, 2026 | Common Stock | SSaleDisposed | −442 | $567.24F2 | −$250,720.08 | 49,571 | Direct | |
| Apr 10, 2026 | Common Stock | SSaleDisposed | −2,105 | $568.00F3 | −$1,195,640 | 47,466 | Direct | |
| Apr 10, 2026 | Common Stock | SSaleDisposed | −3,183 | $568.97F4 | −$1,811,031.51 | 44,283 | Direct | |
| Apr 10, 2026 | Common Stock | SSaleDisposed | −2,056 | $569.97F5 | −$1,171,858.32 | 42,227 | Direct | |
| Apr 10, 2026 | Common Stock | SSaleDisposed | −1,215 | $570.88F6 | −$693,619.2 | 41,012 | Direct | |
| Apr 10, 2026 | Common Stock | SSaleDisposed | −459 | $571.68F7 | −$262,401.12 | 40,553 | Direct | |
| Apr 10, 2026 | Common Stock | SSaleDisposed | −40 | $573.01F8 | −$22,920.4 | 40,513 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 10, 2026 | Common Stock | MOption exerciseDisposed | −9,500 | $0.00 | $0 | 64,500 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $566.44 to $567.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $567.44 to $568.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $568.44 to $569.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $569.45 to $570.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $570.46 to $571.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $571.51 to $571.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $572.96 to $573.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.